Automated description from the Alliance of Genome Resources (Release 7.1.0)
Predicted to enable cyclin binding activity and cyclin-dependent protein serine/threonine kinase activity. Predicted to be involved in several processes, including G0 to G1 transition; G1/S transition of mitotic cell cycle; and negative regulation of Notch signaling pathway. Predicted to be part of cyclin-dependent protein kinase holoenzyme complex. Predicted to be active in cytoplasm and nucleus. Is expressed in several structures, including chondrocranium; heart; hindbrain roof; lung; and nasal cavity. Orthologous to human CDK3 (cyclin dependent kinase 3).